Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
05/23/1985 | WO1985002121A1 Immune response to tumors and viruses induced by anti-idiotype antibodies |
05/22/1985 | EP0142345A2 Anti-idiotypic vaccine employing anti-idiotypic monoclonal antibodies |
05/22/1985 | EP0141939A2 Method of producing a natural immunoabsorbent |
05/21/1985 | CA1187641A1 High impact compositions containing polycyano norbornenes, halogenated polyolefin and abs resin |
05/15/1985 | EP0141783A2 Immune response to tumours and viruses induced by anti-idiotype antibodies |
05/15/1985 | EP0141616A2 Hybrid cell lines producing monoclonal antibodies directed against trichomonas vaginalis determinants |
05/15/1985 | EP0141326A2 Protein PP20, process for its recovery and its use |
05/15/1985 | EP0141079A2 Monoclonal antibodies specific for membrane-associated antigens |
05/15/1985 | EP0140966A1 Process in the purification of biologically active substances. |
05/14/1985 | US4517304 Production of viral antigens |
05/14/1985 | US4517303 Specific binding assays utilizing analyte-cytolysin conjugates |
05/14/1985 | US4517290 Method for enzyme immunoassay and peptide-enzyme conjugate and antibody therefor |
05/14/1985 | US4517289 Kits, organ transplants, rat lymphocyte cells |
05/14/1985 | CA1187076A1 Protein pp.sub.9, process for its enrichment and its isolation and its use |
05/14/1985 | CA1187010A1 Cell-driven viral transfer in eukaryotes |
05/14/1985 | CA1186993A1 Protein (pp in16 xx), a process for concentrating and isolating it, and its use |
05/09/1985 | WO1985001941A1 Method for the purification and isolation of blood clotting proteins using conformation specific antibodies |
05/08/1985 | EP0140689A2 Hybrid cell lines producing monoclonal antibodies directed against treponema and use thereof for immuno-diagnosis of treponemal infections |
05/08/1985 | EP0140498A1 Caries-preventive composition |
05/08/1985 | EP0140127A1 Process for the preparation of immune interferon |
05/07/1985 | US4515895 Diagnosis and treatment of immunoregulatory disorders |
05/07/1985 | US4515894 Hybrid cell line for producing monoclonal antibody to human T cells |
05/07/1985 | US4515893 Hybrid cell line for producing complement-fixing monoclonal antibody to human T cells |
05/07/1985 | US4515776 Removal of aggregates |
05/07/1985 | CA1186622A1 Homogeneous immunoassay with labeled monoclonal anti- analyte |
05/02/1985 | EP0139555A1 Synthetic peptide, process for its preparation, and drugs thereof |
05/02/1985 | EP0139526A2 An insolubilized stable specific binding protein |
05/02/1985 | EP0139447A2 A process for preparing urokinase zymogen |
05/02/1985 | EP0139416A2 Molecularly cloned diagnostic product and method of use |
05/02/1985 | EP0139389A1 Antiidiotypic monoclonal antibody reagents and immunoassays employing antiidiotypic monoclonal antibody reagents |
04/30/1985 | US4514507 Complexing a labelled monoclonal antibody and a supported antibodyerferon; kits |
04/30/1985 | US4514498 Urogential disorders |
04/30/1985 | US4514387 Chemokinesins and chemotaxins of leukocytes and inflamed tissues |
04/30/1985 | CA1186223A1 Isolation of principal outer membrane protein and antigen of chlamydia trachomatis |
04/25/1985 | WO1985001659A1 Monoclonal antibodies against endotoxin of gram-negative bacteria |
04/24/1985 | EP0138704A2 Hepatitis A-subunit antigen |
04/24/1985 | EP0138377A1 Lewis blood group phenotype assay |
04/24/1985 | EP0138222A2 Preparation of monoclonal anti-protein C antibodies |
04/24/1985 | EP0138087A1 Immune interferon and method for its purification |
04/24/1985 | EP0137822A1 Specific antibody to the native form of 2'5'-oligonucleotides, the method of preparation and the use as reagents in immunoassays or for binding 2'5'-oligonucleotides in biological systems. |
04/23/1985 | US4512971 Mitogens of leukocytes and inflamed tissues |
04/23/1985 | US4512970 Chemorecruitins of leukocytes and inflamed tissues |
04/17/1985 | EP0137657A2 Monoclonal antibodies |
04/17/1985 | EP0137492A2 Method for the early diagnosis of malign tumours in mammals and humans |
04/17/1985 | EP0137457A2 Trace-labeled conjugates of metallothionein and target-seeking biologically active molecules |
04/17/1985 | EP0137345A2 Membrane-associated proteins (MP-2), process for obtaining them and their application |
04/17/1985 | EP0137234A2 Physiologically active compositions |
04/16/1985 | US4511661 Identification and separatioon of cell gender |
04/10/1985 | EP0136947A2 Conjugated lipopolysaccharides, process for their preparation and their use as immunizing agents |
04/10/1985 | EP0136938A2 Derivatives of furanes, their preparation and application |
04/10/1985 | EP0136835A2 Process for the preparation of antibody compositions of therapeutic agents having an extended serum half-life |
04/10/1985 | EP0136620A1 Homogeneous immune interferon fragment |
04/10/1985 | EP0136347A1 Insoluble surfaces treated to inhibit non-specific protein binding |
04/03/1985 | EP0135712A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp. |
04/03/1985 | EP0135536A1 Anti-idiotypic antibodies to t cell antigen receptors |
04/02/1985 | US4508819 Contacting with flowing, cell-free lymph |
04/02/1985 | US4508643 Human chorionic govadotropin; low cross-reactivity |
04/02/1985 | CA1184862A1 Filtration method for cell produced antiviral substances |
03/28/1985 | WO1985001298A1 Monoclonal anti-interleukin-2 antibody useful for immunopurification for interleukin-2 |
03/27/1985 | EP0135277A1 Synthetic polypeptides corresponding to portions of proteinoids translated from brain-specific mRNAs, receptors, methods and diagnostics using the same |
03/27/1985 | EP0135159A2 Monoclonal antibody having specificity for the double-stranded conformation of native DNA and diagnostic methods using same |
03/27/1985 | EP0135073A2 Antigens and monoclonal antibodies reactive against merozites of eimeria spp. |
03/27/1985 | EP0135071A2 Luminescence immuno assay for haptenes and a chemiluminescent labeled haptene conjugate to be used in the assay, and a method for its preparation |
03/27/1985 | EP0134803A1 Monoclonal antibody |
03/26/1985 | US4507229 Tissue protein PP4, a process for isolating it and its use |
03/26/1985 | CA1184491A1 Preparation of anti-t-lymphocyte globulin |
03/20/1985 | EP0134631A1 Peptides, pharmaceutical compositions, genes, vectors, host organisms, processes for their production and diagnostic reagents |
03/20/1985 | EP0134552A2 Monoclonal antibody with a high affinity for digoxin |
03/20/1985 | EP0134307A2 Preactivated surfaces of synthetic materials for immobilizing organochemical and biological substances, process for preparing them and their use |
03/14/1985 | WO1985000974A1 Antibody compositions of therapeutic agents having an extended serum half-life |
03/13/1985 | EP0134041A1 N-Chlorocarbonyloxy-5-norbornene-2,3-dicarboximide, process for its preparation and its use |
03/12/1985 | US4504586 Hybridoma tumor cell lines and their monoclonal antibodies to human colony stimulating factor subclass number 1 |
03/05/1985 | CA1183470A1 Hybrid cell line for producing monoclonal antibody to a human prothymocyte antigen, antibody, and methods |
03/05/1985 | CA1183469A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human suppressor t cells, antibody, and method |
03/05/1985 | CA1183451A1 Method for producing a csap tryptic peptide and anti- csap antibodies |
02/28/1985 | WO1985000807A1 Polypeptide-induced monoclonal antibodies to oncoproteins |
02/27/1985 | EP0133553A2 Reagent and process for the quantitative determination of antibodies |
02/27/1985 | EP0133551A2 Monoclonal antibody which recognizes a structure which is common to the human interleukin-2 (TCGF) and to the light chain lambda of human immunoglobulin, and hybridoma cell lines producing this monoclonal antibody |
02/19/1985 | US4500637 Prevention of graft versus host disease following bone marrow transplantation |
02/19/1985 | US4500451 New protein PP13 extracted from human placental tissues and use thereof |
02/14/1985 | WO1985000503A1 Monoclonal antibodies to the h-y antigen, methods of production, applications, and products of manufacture |
02/13/1985 | EP0132488A2 Rat antibody to human chorionic gonadotropin |
02/12/1985 | US4499081 Inhibits myelopoietic system of humans and animals |
02/12/1985 | US4499080 Synthetic ST toxin, process for its preparation and its use as a vaccinating agent |
02/12/1985 | US4499014 Method for purifying gamma-interferon |
02/12/1985 | CA1182406A1 Hybrid cell line for producing complement-fixing monoclonal antibody to human t cells, antibody, and methods |
01/31/1985 | WO1985000381A1 Proteins, pharmaceutical compositions, genes, vectors, host organisms and processes for their production |
01/30/1985 | EP0132281A2 Method of isolating membrane antigens from cells |
01/29/1985 | US4496658 Sensitivbity test for human chlorionic gonadetrophin; imobilizatio |
01/29/1985 | CA1181702A1 Hybrid cell line for producing monoclonal antibody to a human thymocyte antigen, antibody, and methods |
01/23/1985 | EP0132178A1 Process for the preparation of the principal proteins of hemolysed blood in a non denatured form |
01/23/1985 | EP0132021A1 TGF polypeptides, antigenic oligopeptides derived therefrom and antibodies produced therefrom |
01/23/1985 | EP0131878A2 Process for producing human monoclonal antibodies |
01/23/1985 | EP0131836A2 Alkylated Fab or Fc fragments of human IgG, process for their preparation and pharmaceutical compositions |
01/23/1985 | EP0131834A2 Monoclonal antibody having specificity to only one type of an isozyme of human cardiac myosin heavy chain |
01/22/1985 | US4495281 Contains dibenzo(a,d)cycloheptene; dibenz!b,f) azepine and dibenz(b,e)oxepin rings |
01/22/1985 | CA1181342A1 Method for enzyme immunoassay and production of antibody |
01/16/1985 | EP0131552A2 Purified seminal antigenic fraction, process for its preparation and use of said fraction for the dosage of the spermagglutinating antibodies |
01/16/1985 | EP0131424A2 Improvements in or relating to antibody preparations |
01/16/1985 | EP0131418A1 Proteins, pharmaceutical compositons, genes, vectors, host organisms and processes for their production |